Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis

• Main Authors: Audrey Monnin (Author), Amélie Vizeneux (Author), Nicolas Nagot (Author), Sabrina Eymard-Duvernay (Author), Nicolas Meda (Author), Mandisa Singata-Madliki (Author), Grace Ndeezi (Author), James Kashugyera Tumwine (Author), Chipepo Kankasa (Author), Ameena Goga (Author), Thorkild Tylleskär (Author), Philippe Van de Perre (Author), Jean-Pierre Molès (Author)
• Format: Book
• Published: MDPI AG, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Telomere shortening can be enhanced upon human immunodeficiency virus (HIV) infection and by antiretroviral (ARV) exposures. The aim of this study was to evaluate the acute and long-term effect on telomere shortening of two ARV prophylaxes, lopinavir/ritonavir (LPV/r) and lamivudine (3TC), administe...